Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 January 2008

High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system

R. Ruzicka, M. Kozak, V. Bodepudi, R. Loor, J. Zonderman

Ann Transplant 2008; 13(1): 36-36 :: ID: 880194

Abstract

Background: Our objective was to develop a high throughput, robust and simple method for quantification of any combination of immunosuppressants like sirolimus, tacrolimus, everolimus, and cyclosporin A by implementing APCI source and LC column multiplexing system.
Material/Methods: Blood samples were processed with a protein precipitation method and analyzed on 10-2.1 mm Hypersil C18 guard column with 2 min LC gradient method (1 min data collection time with two column switch method). Data was collected in MRM mode where ammoniated adducts of protonated molecules were used as precursor ions for all analytes. Ascomycin and cyclosporin D were used as internal standards. The whole blood calibrators and QC samples with concentrations across calibration range were prepared in house. The method was validated by processing and analyzing QC samples to obtain inter- and intra- assay variability. An interference study along with BioRad QC analysis was conducted to test method robustness. Extracted sample stability in autosampler rack at 8°C was obtained. Method was correlated with immunoassay by analyzing clinical samples.
Results: The quantification was performed with LOQ of 1 ng/mL and a linearity range 1-50 ng/mL for tacrolimus, sirolimus, everolimus and LOQ of 10 ng/mL and a linearity range of 10-2000 ng/mL for cyclosporin A. Intra and inter-assay CV's were all less than 10%. BioRad QC's results met supplier specification. No interferences were detected. Extracted samples were stable in 8°C for at least 24 hours.
Conclusions: Validation data demonstrates high throughput, robust method with a linearity range, accuracy and precision meeting industry standards.

Keywords: immunosuppressants, Everolimus, cyclosporin

Add Comment 0 Comments

In Press

Original article  

Prediction of Renal Graft Function 1 Year After Adult Deceased-Donor Kidney Transplantation Using Variables...

Ann Transplant In Press; DOI: 10.12659/AOT.944603  

Original article  

Impact of Donor-Recipient Relationship on Long-Term Outcomes in Living-Related Donor Kidney Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.945065  

Case report  

Successful Interventional Therapy for Portal Vein Stenosis after Ex Vivo Liver Resection and Autotransplant...

Ann Transplant In Press; DOI: 10.12659/AOT.944851  

Original article  

Urinary Chemokines CXCL9 and CXCL10 Are Non-Invasive Biomarkers of Kidney Transplant Rejection

Ann Transplant In Press; DOI: 10.12659/AOT.944762  

Most Viewed Current Articles

05 Apr 2022 : Original article   12,880

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   9,836

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

12 Jan 2022 : Original article   9,289

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

15 Mar 2022 : Case report   7,052

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358